Related Experiment Video
Updated: Jul 19, 2026
10:46
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Anticoagulation in interventional cardiology: optimizing patient outcome
1Zentrum für Innere Medizin, Medizinische Klinik und Poliklinik I, Universitätsklinikum Charité der Humboldt-Universitát zu Berlin, Germany.
European Heart Journal
|October 28, 1998
Summary
Preventing blood clots after coronary angioplasty is key. Glycoprotein IIb/IIIa inhibitors, particularly abciximab, show promise in reducing thrombotic complications and late restenosis following percutaneous transluminal coronary angioplasty (PTCA).
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Thrombotic complications, including abrupt vessel closure and late restenosis, frequently occur after percutaneous transluminal coronary angioplasty (PTCA).
- Current strategies involve pre-treatment with heparin and aspirin, but optimal regimens remain undefined.
- Alternative anticoagulants like low-molecular-weight heparins and direct thrombin inhibitors lack demonstrated outcome benefits over standard heparin.
Purpose of the Study:
- To evaluate the efficacy of various antithrombotic agents in preventing complications following PTCA.
- To assess the impact of different anticoagulants and antiplatelet agents on acute and late thrombotic events.
- To identify agents that improve long-term outcomes and reduce restenosis rates.
Main Methods:
- Review of clinical trials investigating antithrombotic therapies in the context of PTCA.
- Comparative analysis of heparin, low-molecular-weight heparins, direct thrombin inhibitors, thrombolytic agents, and glycoprotein IIb/IIIa inhibitors.
- Examination of data on short-term (30-day) and long-term outcomes, including restenosis.
Main Results:
- Heparin and aspirin pre-treatment reduce thrombosis, but optimal use is not established.
- Continued heparin post-PTCA offers no benefit without angiographic thrombosis.
- Glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) combined with aspirin and heparin show positive results.
- Abciximab demonstrated significantly improved 30-day outcomes and reduced late restenosis.
Conclusions:
- Glycoprotein IIb/IIIa inhibitors represent a significant advancement in managing PTCA-related thrombosis.
- Abciximab is particularly effective, showing benefits in both acute outcomes and late restenosis prevention.
- Further research may refine the use of other antithrombotic agents, but current evidence favors glycoprotein IIb/IIIa inhibitors for comprehensive risk reduction.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...